Renaissance Technologies LLC has recently announced that it has increased stake in Passage Bio Inc (NASDAQ:PASG) by 1.56%. After grabbing 0.99 million shares, the institutional investor is now in possession of 15304.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.81% having worth around $0.63 million. Moreover, Acadian Asset Management LLC increased its share by 25872.0 to have a control over 0.6 million shares. And Bridgeway Capital Management LLC raised its holdings to 0.12 million shares by acquiring 0.51 million shares or 0.92% of the stake.
Passage Bio Inc (PASG) concluded trading on December 20, 2023 at a closing price of $0.81, with 16.14 million shares of worth about $13.07 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.83% during that period and On Wednesday the price saw a gain of about 7.35%. Currently the company’s common shares owned by public are about 54.61M shares, out of which, 35.27M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 7 times over the past 12 months. They bought 625,195 shares in 4 of the transactions. In 3 selling transactions, insiders dumped 17,558 shares.
Worldwide Healthcare Trust Plc, Vanguard Total Stock Market ETF, and JPMorgan Funds – Thematics – Gene are the top 3 mutual funds which are holding stakes in Passage Bio Inc Worldwide Healthcare Trust Plc is currently holding 2.09 million shares of worth totaling $1.32 million. The company recently came buying 0.0 shares which brought its stake up to 3.81% of the company’s outstanding shares. JPMorgan Funds – Thematics – Gene, after selling 0.59 million shares, have now control over 1.07% of the stake in the company. It holds -0.16 million shares of worth $0.37 million.
However, the stock later moved at a day high price of 0.9023, or with a gain of 7.35%. Stock saw a price change of 16.40% in past 5 days and over the past one month there was a price change of 29.48%. Year-to-date (YTD), PASG shares are showing a performance of -40.96% which decreased to -30.95% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.58 but also hit the highest price of $1.92 during that period. The average intraday trading volume for Passage Bio Inc shares is 253.06K. The stock is currently trading 22.46% above its 20-day simple moving average (SMA20), while that difference is up 23.74% for SMA50 and it goes to -4.52% lower than SMA200.
Renaissance Technologies LLC acquired 0.99 million shares of Passage Bio Inc having value of about $0.63 million. Data submitted at the U.S SEC by Renaissance Technologies LLC revealed that the firm now holds 15304.0 shares in the company valued at close to $12396.24, or have control over 1.56% stake in the company. Passage Bio Inc (NASDAQ: PASG) currently have 54.61M outstanding shares and institutions hold larger chunk of about 19.44% of that. Holding of mutual funds in the company is about 26.94% while other institutional holders and individual stake holders have control over 8.71% and 10.74% of the stake respectively.
The stock has a current market capitalization of $44.67M and its 3Y-monthly beta is at 1.03. It has posted earnings per share of -$2.06 in the same period. It has Quick Ratio of 6.85 while making debt-to-equity ratio of 0.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PASG, volatility over the week remained 10.61% while standing at 10.03% over the month.
Analysts are in expectations that Passage Bio Inc (PASG) stock would likely to be making an EPS of -$0.43 in the current quarter, while forecast for next quarter EPS is -$0.4 and it is -$1.31 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.47 which is -$0.38 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.49 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 23.92% while it is estimated to increase by 29.86% in next year.
